Articles on Gene Editing

Gene editing technologies, including CRISPR, are transforming biotech research and therapeutic development. This section covers precision tools, evolving gene editing platforms, and the ethical and regulatory considerations shaping the field.



Featured Article

IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme

In a groundbreaking development for the biotech industry, KACTUS's GMP-grade Cas9 has critically helped Yizun Bio secure IND clearance for a universal solid tumor cell therapy. Yizun Bio’s CNK-UT002 cell injection, an innovative allogeneic T cell therapy designed for advanced solid tumors such as liver cancer and melanoma,

Browse articles by topic:

Breaking News: KACTUS GMP-Grade Cas9 Powers Bioheng’s Breakthrough IND Clearance for Next-Gen UCAR-T Therapy

March 5, 2025

4 min read

NK Cell Therapy Gets IND FDA Clearance with AccuBase® Base Editor from KACTUS

November 21, 2024

5 min read

2024 Milestones in CRISPR Clinical Pipelines

November 11, 2024

5 min read

Base Editing Technology Leads a New Chapter in Drug Development

February 14, 2024

5 min read

The New Frontier in SCLC Treatment: 4 Antigens Driving Antibody Innovation

June 25, 2025

9 min read

STEAP1, the next blockbuster target for Prostate Cancer

June 16, 2025

5 min read

Targeted Therapies for Inflammatory Bowel Disease (IBD)

May 28, 2025

6 min read

The Landscape of GPCR-targeting Antibody Drug Development

May 9, 2025

9 min read

For Better Symptom Relief: Targeted Therapy for Asthma

April 15, 2025

11 min read

At the Crossroads of Metabolic and Cancer Therapeutics — GDF15

April 1, 2025

7 min read

NPR1: Major Drug Target for Heart Failure

February 25, 2025

5 min read

Immunotherapy Target: CD19 Antigen

February 4, 2025

7 min read

Case Review: Exploring domain proteins in antibody development

January 22, 2025

8 min read

GDF-8 (Myostatin) antibody Apitegromab achieves success in Phase III clinical trial

June 13, 2024

4 min read

MSLN Targeted Drugs Entering the Fast Lane

February 29, 2024

5 min read

New target for colorectal cancer: GPA33

February 24, 2023

4 min read

1 2
The Rise of Allogeneic Cell Therapies: Strategies, Challenges, and Clinical Advances

April 8, 2025

7 min read

CDH17: A Safe CAR-T Target for Treatment of Solid Tumors

July 19, 2022

5 min read

MRGPRX2: A Promising Target for Antibody Discovery in Allergy and Pain Disorders

October 28, 2024

6 min read

GPCRs for Drug Discovery and Development

September 20, 2023

2 min read

TM4SF1 in Cancer Immunotherapy: Emerging Research and Clinical Potential

September 5, 2022

5 min read

Beyond GLP-1: ALK7–Activin E as a More Targeted Approach to Obesity Therapy

December 15, 2025

7 min read

GDF-8: A New Era in Muscle Growth Therapies is Coming to Market

December 9, 2025

4 min read

KLK2: The New Promising Target for Prostate Cancer

December 4, 2025

4 min read

CDCP1: A New Therapeutic Target for Malignant Tumors

November 26, 2025

6 min read

IgE:  The Key Therapeutic Target for Allergy Treatment

November 20, 2025

7 min read

CDH17: The Next Breakthrough in Gastrointestinal Cancer Therapy

November 12, 2025

7 min read

FcRh5: An Emerging Therapeutic Target in Multiple Myeloma

October 22, 2025

7 min read

BAFF and APRIL: Key Targets in Autoimmune Diseases and a Review of Dual- and Single-Target Inhibitors

August 13, 2025

8 min read

A New Era in Targeted Therapies: Ichnos Glenmark Innovation and AbbVie Blaze a Trail with Tri-specific Antibodies

July 29, 2025

3 min read

KACTUS Unveils Ultra-low Endotoxin Recombinant Protein Line — Powering Cleaner, Faster, Smarter Drug Discovery

July 10, 2025

1 min read

Why Endotoxin Testing Matters: Safeguarding Recombinant Protein Applications in Immunology and Drug Discovery

May 22, 2025

4 min read

MASP2 Antibody Successful in Phase III Clinical Trial

February 10, 2025

5 min read

1 2 3
Nanodiscs: A Versatile Platform for Membrane Protein Research

April 28, 2025

8 min read

Addressing Challenging Antibody Discovery Targets with Virus-like Particle (VLP) Transmembrane Proteins

October 2, 2024

5 min read

Virus-like Particles: What they are and what they can o in Antibody Discovery

August 28, 2024

6 min read

Rewriting Life's Code: CRISPR Precisely Edits Blood Disorder Defects

August 5, 2025

3 min read

AAV Capsid Optimization and Precision Quantification: Customized AAV ELISA Detection Solutions

June 4, 2025

2 min read

Ensuring Safe and Effective Gene Therapy with Precise AAV Capsid Quantification

March 25, 2025

6 min read

Breaking News: KACTUS GMP-Grade Cas9 Powers Bioheng’s Breakthrough IND Clearance for Next-Gen UCAR-T Therapy

March 5, 2025

4 min read

Effective Serratia marcescens Nuclease for DNA & RNA Removal: MaxNuclease™

February 21, 2025

3 min read

Panorama of CRISPR Gene Editing Clinical Applications: 2024 Review

January 31, 2025

8 min read

NK Cell Therapy Gets IND FDA Clearance with AccuBase® Base Editor from KACTUS

November 21, 2024

5 min read

2024 Milestones in CRISPR Clinical Pipelines

November 11, 2024

5 min read

Base Editing vs. CRISPR: Navigating Precision Gene Therapy

October 14, 2024

5 min read

AccuBase™ Base Editor Continues to Advance NK Cell Therapies

July 31, 2024

4 min read

IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme

July 24, 2024

4 min read

Gene Editing Drugs from the EMA Review Perspective

June 25, 2024

5 min read

1 2

Have questions? Get in touch!

support@kactusbio.us